Global Group A and Group C Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029
The global Group A and Group C Meningococcal Polysaccharide Vaccine market size is expected to reach $ 430.2 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).
Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.
This report studies the global Group A and Group C Meningococcal Polysaccharide Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Group A and Group C Meningococcal Polysaccharide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Group A and Group C Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Group A and Group C Meningococcal Polysaccharide Vaccine total production and demand, 2018-2029, (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine total production value, 2018-2029, (USD Million)
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Group A and Group C Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Group A and Group C Meningococcal Polysaccharide Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Walvax, Lanzhou Institute of Biological Products, AIM Bio, Sanofi Pasteur, GSK, Hualan Bio, ZFSW, Changsheng and Kanghua Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Group A and Group C Meningococcal Polysaccharide Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, By Region:
1. How big is the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
2. What is the demand of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
3. What is the year over year growth of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
4. What is the production and production value of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
5. Who are the key producers in the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
6. What are the growth factors driving the market demand?
Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.
This report studies the global Group A and Group C Meningococcal Polysaccharide Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Group A and Group C Meningococcal Polysaccharide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Group A and Group C Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Group A and Group C Meningococcal Polysaccharide Vaccine total production and demand, 2018-2029, (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine total production value, 2018-2029, (USD Million)
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Group A and Group C Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Group A and Group C Meningococcal Polysaccharide Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Group A and Group C Meningococcal Polysaccharide Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Walvax, Lanzhou Institute of Biological Products, AIM Bio, Sanofi Pasteur, GSK, Hualan Bio, ZFSW, Changsheng and Kanghua Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Group A and Group C Meningococcal Polysaccharide Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Class 1 Vaccine
- Class II Vaccine
- Hospital
- Clinic
- Walvax
- Lanzhou Institute of Biological Products
- AIM Bio
- Sanofi Pasteur
- GSK
- Hualan Bio
- ZFSW
- Changsheng
- Kanghua Bio
1. How big is the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
2. What is the demand of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
3. What is the year over year growth of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
4. What is the production and production value of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
5. Who are the key producers in the global Group A and Group C Meningococcal Polysaccharide Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Group A and Group C Meningococcal Polysaccharide Vaccine Introduction
1.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Supply & Forecast
1.2.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.2.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Pricing Trends (2018-2029)
1.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (Based on Production Site)
1.3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2018-2029)
1.3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (2018-2029)
1.3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2029)
1.3.4 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.3.5 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.3.6 China Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.3.7 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Group A and Group C Meningococcal Polysaccharide Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Demand (2018-2029)
2.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption by Region
2.2.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption by Region (2018-2023)
2.2.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.4 China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.5 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.6 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.7 South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.8 ASEAN Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.9 India Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
3 WORLD GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Manufacturer (2018-2023)
3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023)
3.4 Group A and Group C Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Group A and Group C Meningococcal Polysaccharide Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Group A and Group C Meningococcal Polysaccharide Vaccine in 2022
3.6 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.6.2 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.6.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Comparison
4.1.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Comparison
4.2.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Comparison
4.3.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023)
4.5 China Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share
4.5.1 China Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023)
4.6 Rest of World Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Class 1 Vaccine
5.2.2 Class II Vaccine
5.3 Market Segment by Type
5.3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Type (2018-2029)
5.3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type (2018-2029)
5.3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Application (2018-2029)
6.3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application (2018-2029)
6.3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Walvax
7.1.1 Walvax Details
7.1.2 Walvax Major Business
7.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.1.4 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Walvax Recent Developments/Updates
7.1.6 Walvax Competitive Strengths & Weaknesses
7.2 Lanzhou Institute of Biological Products
7.2.1 Lanzhou Institute of Biological Products Details
7.2.2 Lanzhou Institute of Biological Products Major Business
7.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.2.4 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.2.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
7.3 AIM Bio
7.3.1 AIM Bio Details
7.3.2 AIM Bio Major Business
7.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.3.4 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AIM Bio Recent Developments/Updates
7.3.6 AIM Bio Competitive Strengths & Weaknesses
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Details
7.4.2 Sanofi Pasteur Major Business
7.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.4.4 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Pasteur Recent Developments/Updates
7.4.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.5 GSK
7.5.1 GSK Details
7.5.2 GSK Major Business
7.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.5.4 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GSK Recent Developments/Updates
7.5.6 GSK Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.6.4 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 ZFSW
7.7.1 ZFSW Details
7.7.2 ZFSW Major Business
7.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.7.4 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 ZFSW Recent Developments/Updates
7.7.6 ZFSW Competitive Strengths & Weaknesses
7.8 Changsheng
7.8.1 Changsheng Details
7.8.2 Changsheng Major Business
7.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.8.4 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Changsheng Recent Developments/Updates
7.8.6 Changsheng Competitive Strengths & Weaknesses
7.9 Kanghua Bio
7.9.1 Kanghua Bio Details
7.9.2 Kanghua Bio Major Business
7.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.9.4 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Kanghua Bio Recent Developments/Updates
7.9.6 Kanghua Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
8.2 Group A and Group C Meningococcal Polysaccharide Vaccine Upstream Analysis
8.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Group A and Group C Meningococcal Polysaccharide Vaccine Production Mode
8.6 Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
8.7 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels
8.7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
8.7.2 Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Group A and Group C Meningococcal Polysaccharide Vaccine Introduction
1.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Supply & Forecast
1.2.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.2.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Pricing Trends (2018-2029)
1.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (Based on Production Site)
1.3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2018-2029)
1.3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (2018-2029)
1.3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2029)
1.3.4 North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.3.5 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.3.6 China Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.3.7 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Group A and Group C Meningococcal Polysaccharide Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Demand (2018-2029)
2.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption by Region
2.2.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption by Region (2018-2023)
2.2.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.4 China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.5 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.6 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.7 South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.8 ASEAN Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
2.9 India Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
3 WORLD GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Manufacturer (2018-2023)
3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023)
3.4 Group A and Group C Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Group A and Group C Meningococcal Polysaccharide Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Group A and Group C Meningococcal Polysaccharide Vaccine in 2022
3.6 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.6.2 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.6.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Comparison
4.1.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Comparison
4.2.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Comparison
4.3.1 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023)
4.5 China Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share
4.5.1 China Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023)
4.6 Rest of World Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Class 1 Vaccine
5.2.2 Class II Vaccine
5.3 Market Segment by Type
5.3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Type (2018-2029)
5.3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type (2018-2029)
5.3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Application (2018-2029)
6.3.2 World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application (2018-2029)
6.3.3 World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Walvax
7.1.1 Walvax Details
7.1.2 Walvax Major Business
7.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.1.4 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Walvax Recent Developments/Updates
7.1.6 Walvax Competitive Strengths & Weaknesses
7.2 Lanzhou Institute of Biological Products
7.2.1 Lanzhou Institute of Biological Products Details
7.2.2 Lanzhou Institute of Biological Products Major Business
7.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.2.4 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.2.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
7.3 AIM Bio
7.3.1 AIM Bio Details
7.3.2 AIM Bio Major Business
7.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.3.4 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AIM Bio Recent Developments/Updates
7.3.6 AIM Bio Competitive Strengths & Weaknesses
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Details
7.4.2 Sanofi Pasteur Major Business
7.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.4.4 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Pasteur Recent Developments/Updates
7.4.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.5 GSK
7.5.1 GSK Details
7.5.2 GSK Major Business
7.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.5.4 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GSK Recent Developments/Updates
7.5.6 GSK Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.6.4 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 ZFSW
7.7.1 ZFSW Details
7.7.2 ZFSW Major Business
7.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.7.4 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 ZFSW Recent Developments/Updates
7.7.6 ZFSW Competitive Strengths & Weaknesses
7.8 Changsheng
7.8.1 Changsheng Details
7.8.2 Changsheng Major Business
7.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.8.4 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Changsheng Recent Developments/Updates
7.8.6 Changsheng Competitive Strengths & Weaknesses
7.9 Kanghua Bio
7.9.1 Kanghua Bio Details
7.9.2 Kanghua Bio Major Business
7.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
7.9.4 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Kanghua Bio Recent Developments/Updates
7.9.6 Kanghua Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
8.2 Group A and Group C Meningococcal Polysaccharide Vaccine Upstream Analysis
8.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Group A and Group C Meningococcal Polysaccharide Vaccine Production Mode
8.6 Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
8.7 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels
8.7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
8.7.2 Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2018-2023)
Table 9. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2024-2029)
Table 10. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Group A and Group C Meningococcal Polysaccharide Vaccine Major Market Trends
Table 13. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Group A and Group C Meningococcal Polysaccharide Vaccine Producers in 2022
Table 18. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Group A and Group C Meningococcal Polysaccharide Vaccine Producers in 2022
Table 20. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Group A and Group C Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
Table 22. World Group A and Group C Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Group A and Group C Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 24. Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 25. Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 26. Group A and Group C Meningococcal Polysaccharide Vaccine Competitive Factors
Table 27. Group A and Group C Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
Table 28. Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Group A and Group C Meningococcal Polysaccharide Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
Table 37. China Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
Table 47. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Walvax Basic Information, Manufacturing Base and Competitors
Table 62. Walvax Major Business
Table 63. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 64. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Walvax Recent Developments/Updates
Table 66. Walvax Competitive Strengths & Weaknesses
Table 67. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 68. Lanzhou Institute of Biological Products Major Business
Table 69. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 70. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 72. Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
Table 73. AIM Bio Basic Information, Manufacturing Base and Competitors
Table 74. AIM Bio Major Business
Table 75. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 76. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AIM Bio Recent Developments/Updates
Table 78. AIM Bio Competitive Strengths & Weaknesses
Table 79. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Pasteur Major Business
Table 81. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 82. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Pasteur Recent Developments/Updates
Table 84. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 85. GSK Basic Information, Manufacturing Base and Competitors
Table 86. GSK Major Business
Table 87. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 88. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GSK Recent Developments/Updates
Table 90. GSK Competitive Strengths & Weaknesses
Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 92. Hualan Bio Major Business
Table 93. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 94. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hualan Bio Recent Developments/Updates
Table 96. Hualan Bio Competitive Strengths & Weaknesses
Table 97. ZFSW Basic Information, Manufacturing Base and Competitors
Table 98. ZFSW Major Business
Table 99. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 100. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. ZFSW Recent Developments/Updates
Table 102. ZFSW Competitive Strengths & Weaknesses
Table 103. Changsheng Basic Information, Manufacturing Base and Competitors
Table 104. Changsheng Major Business
Table 105. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 106. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Changsheng Recent Developments/Updates
Table 108. Kanghua Bio Basic Information, Manufacturing Base and Competitors
Table 109. Kanghua Bio Major Business
Table 110. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 111. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Group A and Group C Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)
Table 113. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers
Table 114. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors
Table 1. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2018-2023)
Table 9. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2024-2029)
Table 10. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Group A and Group C Meningococcal Polysaccharide Vaccine Major Market Trends
Table 13. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Group A and Group C Meningococcal Polysaccharide Vaccine Producers in 2022
Table 18. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Group A and Group C Meningococcal Polysaccharide Vaccine Producers in 2022
Table 20. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Group A and Group C Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
Table 22. World Group A and Group C Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Group A and Group C Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 24. Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 25. Group A and Group C Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 26. Group A and Group C Meningococcal Polysaccharide Vaccine Competitive Factors
Table 27. Group A and Group C Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
Table 28. Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Group A and Group C Meningococcal Polysaccharide Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
Table 37. China Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
Table 47. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Group A and Group C Meningococcal Polysaccharide Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Walvax Basic Information, Manufacturing Base and Competitors
Table 62. Walvax Major Business
Table 63. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 64. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Walvax Recent Developments/Updates
Table 66. Walvax Competitive Strengths & Weaknesses
Table 67. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 68. Lanzhou Institute of Biological Products Major Business
Table 69. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 70. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 72. Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
Table 73. AIM Bio Basic Information, Manufacturing Base and Competitors
Table 74. AIM Bio Major Business
Table 75. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 76. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AIM Bio Recent Developments/Updates
Table 78. AIM Bio Competitive Strengths & Weaknesses
Table 79. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Pasteur Major Business
Table 81. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 82. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Pasteur Recent Developments/Updates
Table 84. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 85. GSK Basic Information, Manufacturing Base and Competitors
Table 86. GSK Major Business
Table 87. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 88. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GSK Recent Developments/Updates
Table 90. GSK Competitive Strengths & Weaknesses
Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 92. Hualan Bio Major Business
Table 93. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 94. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hualan Bio Recent Developments/Updates
Table 96. Hualan Bio Competitive Strengths & Weaknesses
Table 97. ZFSW Basic Information, Manufacturing Base and Competitors
Table 98. ZFSW Major Business
Table 99. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 100. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. ZFSW Recent Developments/Updates
Table 102. ZFSW Competitive Strengths & Weaknesses
Table 103. Changsheng Basic Information, Manufacturing Base and Competitors
Table 104. Changsheng Major Business
Table 105. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 106. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Changsheng Recent Developments/Updates
Table 108. Kanghua Bio Basic Information, Manufacturing Base and Competitors
Table 109. Kanghua Bio Major Business
Table 110. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product and Services
Table 111. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Group A and Group C Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)
Table 113. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers
Table 114. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Group A and Group C Meningococcal Polysaccharide Vaccine Picture
Figure 2. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 5. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 10. China Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 12. Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Group A and Group C Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Group A and Group C Meningococcal Polysaccharide Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Group A and Group C Meningococcal Polysaccharide Vaccine Markets in 2022
Figure 26. United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share 2022
Figure 32. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Type in 2022
Figure 34. Class 1 Vaccine
Figure 35. Class II Vaccine
Figure 36. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
Figure 47. Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
Figure 48. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
Figure 49. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Group A and Group C Meningococcal Polysaccharide Vaccine Picture
Figure 2. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 5. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 10. China Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Units)
Figure 12. Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Group A and Group C Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Group A and Group C Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Group A and Group C Meningococcal Polysaccharide Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Group A and Group C Meningococcal Polysaccharide Vaccine Markets in 2022
Figure 26. United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share 2022
Figure 32. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Type in 2022
Figure 34. Class 1 Vaccine
Figure 35. Class II Vaccine
Figure 36. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Group A and Group C Meningococcal Polysaccharide Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Group A and Group C Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
Figure 47. Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
Figure 48. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
Figure 49. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
